Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak S Lala

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|July 10, 2016
Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeysBradford S Hamilton, Corinna Schoelch, Annette Schuler-Metz, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanismYu Li, Charles Bolten, B Ganesh Bhat, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Recent Progress in Hormone Research|May 23, 2002
Steroidogenic factor 1: an essential mediator of endocrine developmentKeith L Parker, Douglas A Rice, Deepak S Lala, et al.
European Journal of Pharmacology|December 3, 2014
Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S Hamilton, Frank Himmelsbach, Herbert Nar, et al.
Bioorganic & Medicinal Chemistry|February 22, 2016
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonistsStephen D Lotesta, Andrew P Marcus, Yajun Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarringMark L Boys, Feng Bian, James B Kramer, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|July 10, 2016
Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeysBradford S Hamilton, Corinna Schoelch, Annette Schuler-Metz, et al.
Molecular Endocrinology (Baltimore, Md.)|March 5, 2002
Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanismYu Li, Charles Bolten, B Ganesh Bhat, et al.
Molecular Endocrinology (Baltimore, Md.)|March 12, 2005
The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanismsMonica L Hultman, Nataliia V Krasnoperova, Suzhen Li, et al.
Recent Progress in Hormone Research|May 23, 2002
Steroidogenic factor 1: an essential mediator of endocrine developmentKeith L Parker, Douglas A Rice, Deepak S Lala, et al.
European Journal of Pharmacology|December 3, 2014
Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetesBradford S Hamilton, Frank Himmelsbach, Herbert Nar, et al.
Bioorganic & Medicinal Chemistry|February 22, 2016
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonistsStephen D Lotesta, Andrew P Marcus, Yajun Zheng, et al.
Bioorganic & Medicinal Chemistry Letters|May 1, 2012
Discovery of a series of 2-(1H-pyrazol-1-yl)pyridines as ALK5 inhibitors with potential utility in the prevention of dermal scarringMark L Boys, Feng Bian, James B Kramer, et al.
Pageof 2